Citizens Financial Group (CFG)

Banca comercial regional

Large-scale regional bank (US$233,800 million in assets) in a profitability recovery phase: ROTCE rose from 9.8% (FY24) to 13.9% (2Q26) on NIM expansion, expense discipline and the Private Bank ramp. At the market price, the estimated 5-year return is +12% (Undervalued), with It trades at a real discount to value, though short of the required margin of safety. and a dividend growing steadily on a moderate payout (35-40%).

Moat Compounder estimates the intrinsic value of Citizens Financial Group (CFG) at $97 per share on a five-year horizon. With the stock at $63.90 at 2026-10-12 close, the expected total return is 11.7% per year: undervalued. The analysis draws on 10-K FY2025 and 8-K 2Q2026. Analysis dated 2026-08-03.

Price
$63.90
at 2026-10-12 close
Intrinsic value (5y, base)
$97
Total annual return (5y)
11.7%
8.7% price · 3.1% div
Status (nominal)
Undervalued
Margin of safety
+27%

The essentials

  • ROTCE in structural recovery: 9.8% (FY24) → 11.2% (FY25) → 13.9% (2Q26), with NIM expanding 22bp year over year and positive operating leverage (+6.4% year over year).
  • Private Bank and wealth management already contributed US$0.15 of EPS in 2Q26 (up from US$0.11 in 1Q26), the highest-margin growth lever within the bank.
  • Solid balance sheet: CET1 10.4% (with a cushion of ~140bp over the effective regulatory minimum of 9.0%), reserve coverage 152% of nonperforming loans, net charge-offs declining (0.37% annualized).
Source 10-K FY2025 Dec 31, 2025 ·8-K 2Q2026 Jun 30, 2026
Health: Under watch
Price $64 at 2026-10-12 closeMarket Cap $27.3 bnDeposits $185.6 bnP/tangible book 1.7xROTCE 12.5%P/E (today) 13.7x

Intrinsic value — two valuation methods

Fairly valued
Price market
$64
DCF value today
$157
+145.8% vs price
Multiples value today
$88
+37.5% vs price

Total return at 5 years: 11.7%/year = 8.7% appreciation + 3.1% dividend. The target price ($97) is ex-dividend; the $12 in dividends collected over 5 years are added separately.

By both methods, the value today (DCF $157 · Multiples $88) exceeds the market price ($64).

Pillars of the analysis

The verdict — today vs 5 years

Today — fairly valued: at $64 trades ~27.3% below its value discounted to today (~$88); the discount is positive but does not reach the margin of safety we require (≥38%).

At 5 years — Infravalorado: the target price ($97) plus dividends yield above the required average return (10%) — the business compounds.

The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$56.

Thesis

The business

Citizens is a large-scale regional bank (US$233,800 million in assets) in a profitability recovery phase: ROTCE rose from 9.8% (FY24) to 11.2% (FY25) and 13.9% (2Q26), driven by NIM expansion (+22bp year over year), expense discipline from the Reimagine the Bank program and the Private Bank and Private Wealth ramp, the highest-margin business within the bank. The moat is narrow and stable: distribution and funding scale, plus regulatory barriers, without a dominant advantage against larger national banks.

The valuation

Valued by normalized P/E on TTM common earnings, within the method's standard bank band, with P/tangible book as a cross-check. The base multiple (12.0x) reflects a mid-low position in the band due to the narrow/stable moat and an ROTCE still below top-tier peers. At the market price, the estimated 5-year return is +12% (Undervalued).

The margin of safety

It trades at a real discount to value, though short of the required margin of safety. The dividend (yield 2.9%) grows with payout headroom (35-40%), supported by the earnings recovery and without compromising CET1 capital build.

What to watch

The key disconfirmer is the credit cycle: a deterioration in borrower quality would raise net charge-offs (currently 0.37%) and provisioning, reversing the ROTCE improvement that supports the thesis. Also watch whether NIM expansion and Reimagine the Bank efficiencies hold, and whether the Private Bank ramp maintains its pace of contribution to earnings per share.

Educational / informational. Does not constitute investment advice.

Other companies of the same type